Increased NF-κB activity reinforces the intrinsic therapy-resistance phenotype of thyroid cancer cells, and its inhibition has been showing promising results in combination with chemotherapy or radiotherapy [9], [10]. Here, NFKB1 is linked to thyroid gland carcinoma.